![Ross Breckenridge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ross Breckenridge
Directeur Général chez Arjuna Therapeutics
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Charlie Sheppard | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Graeme Martin | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Tamara Elias | M | 53 | 4 ans | |
Tatiana López del Río | F | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Darren Bianchi | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Robert Barnes | M | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Leigh F. Elkolli | F | - | - | |
Katrina L. Thompson | F | 65 | 14 ans | |
Stephen Oesterle | M | 73 | 1 ans | |
Brandi Roberts | F | 50 | 2 ans | |
Anne Jillian Keating | F | 70 | 7 ans | |
Gordon E. Nye | M | 69 | 18 ans | |
C. Larkin | M | 75 | 2 ans | |
Robert K. Schultz | M | 68 | 14 ans | |
R. Huennekens | M | 59 | 3 ans | |
Regina Groves | F | 66 | 4 ans | |
Richard Kimes | M | 62 | 2 ans | |
Donald K. Brandom | M | 64 | 13 ans | |
David Eisler | M | 45 | 1 ans | |
Joann Lofgren Yao | F | - | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 15 | 75,00% |
Espagne | 5 | 25,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Ross Breckenridge
- Réseau Personnel